EcoDrugPlus

Trace Amine Associated Receptor 1

Ensembl ID : ENSMMDG00005010583
Gene Symbol: TAAR1
1 Cross references
620 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSMMDG00005010589
Gene Symbol: TAAR1
1 Cross references
620 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSMMDG00005010588
Gene Symbol: TAAR1
1 Cross references
620 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSMMDG00005010573
Gene Symbol: TAAR1
1 Cross references
620 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSMMDG00005010578
Gene Symbol: TAAR1
3 Cross references
620 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSMMDG00005010582
Gene Symbol: TAAR1
1 Cross references
620 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSMMDG00005010585
Gene Symbol: TAAR1
1 Cross references
620 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSMMDG00005000029
Gene Symbol: TAAR1
3 Cross references
365 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSMMDG00005010595
Gene Symbol: TAAR1
1 Cross references
620 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSMMDG00005000009
Gene Symbol: TAAR1
1 Cross references
365 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSMMDG00005010580
Gene Symbol: TAAR1
1 Cross references
620 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSMMDG00005000005
Gene Symbol: TAAR1
1 Cross references
365 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).